BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,105 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,017,245 | -40.1% | 120,097 | -23.5% | 0.05% | -48.5% |
Q1 2024 | $6,707,744 | -25.4% | 156,943 | -32.6% | 0.10% | -39.5% |
Q4 2023 | $8,997,496 | +253.4% | 232,734 | +245.0% | 0.17% | +215.1% |
Q3 2023 | $2,546,091 | -63.2% | 67,464 | -55.5% | 0.05% | -64.7% |
Q2 2023 | $6,914,459 | +1419.2% | 151,766 | +1252.5% | 0.15% | +1263.6% |
Q1 2023 | $455,124 | -52.3% | 11,221 | -40.1% | 0.01% | -59.3% |
Q4 2022 | $954,617 | +14.7% | 18,729 | +21.3% | 0.03% | +8.0% |
Q3 2022 | $832,000 | -68.7% | 15,445 | -50.1% | 0.02% | -70.9% |
Q4 2021 | $2,655,000 | +299.2% | 30,932 | +274.1% | 0.09% | +218.5% |
Q3 2021 | $665,000 | -39.0% | 8,269 | -38.9% | 0.03% | -41.3% |
Q2 2021 | $1,090,000 | -23.7% | 13,542 | -20.1% | 0.05% | -28.1% |
Q1 2021 | $1,429,000 | +540.8% | 16,946 | +511.1% | 0.06% | +814.3% |
Q3 2020 | $223,000 | -92.2% | 2,773 | -91.7% | 0.01% | -91.9% |
Q2 2020 | $2,865,000 | -3.5% | 33,281 | -9.0% | 0.09% | +4.9% |
Q1 2020 | $2,970,000 | +203.7% | 36,578 | +227.2% | 0.08% | +382.4% |
Q3 2019 | $978,000 | -10.6% | 11,178 | -16.3% | 0.02% | 0.0% |
Q2 2019 | $1,094,000 | -79.3% | 13,352 | -79.5% | 0.02% | -77.9% |
Q1 2019 | $5,287,000 | -2.3% | 65,025 | -20.9% | 0.08% | -8.3% |
Q4 2018 | $5,411,000 | +5.5% | 82,204 | +23.5% | 0.08% | +18.3% |
Q3 2018 | $5,131,000 | -63.5% | 66,565 | -69.2% | 0.07% | -64.0% |
Q1 2018 | $14,056,000 | +466.5% | 216,107 | +463.0% | 0.20% | +447.2% |
Q4 2017 | $2,481,000 | -78.6% | 38,386 | -79.3% | 0.04% | -78.9% |
Q3 2017 | $11,616,000 | -29.2% | 185,121 | -31.7% | 0.17% | -25.7% |
Q2 2017 | $16,398,000 | -68.9% | 270,869 | -73.4% | 0.23% | -65.7% |
Q1 2017 | $52,766,000 | -6.4% | 1,017,461 | -20.0% | 0.67% | -7.7% |
Q4 2016 | $56,395,000 | +85.7% | 1,271,879 | +99.3% | 0.73% | +83.3% |
Q3 2016 | $30,372,000 | -20.9% | 638,063 | -24.9% | 0.40% | -13.9% |
Q2 2016 | $38,398,000 | -44.9% | 849,128 | -49.9% | 0.46% | -41.1% |
Q1 2016 | $69,633,000 | +315.0% | 1,695,068 | +592.1% | 0.78% | +510.2% |
Q1 2015 | $16,778,000 | +4315.3% | 244,934 | +4623.0% | 0.13% | +4166.7% |
Q4 2014 | $380,000 | – | 5,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |